JP Morgan Chase
PACB icon

JP Morgan Chase’s Pacific Biosciences PACB Stock Holding History

JP Morgan Chase’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-69,600
Closed -$359K – 5807
2019
Q3 		$359K Buy
+69,600
New +$389K ﹤0.01% 4332
2019
Q2 		– Sell
-2,000
Closed -$14K – 5933
2019
Q1 		$14K Sell
2,000
-239,200
-99% -$1.73M ﹤0.01% 5477
2018
Q4 		$1.78M Buy
+241,200
New +$1.53M ﹤0.01% 3359
2016
Q2 		– Sell
-15,000
Closed -$128K – 4910
2016
Q1 		$128K Buy
+15,000
New +$148K ﹤0.01% 3703

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

JP Morgan Chase's PACB Position: Q2 2026 in Review

JP Morgan Chase increased its Pacific Biosciences (PACB) stake by 5.4% in Q2 2026, buying an estimated $10.8K and bringing the position to 145,948 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #5498.

JP Morgan Chase first reported a position in PACB in Q2 2013 and has held it in 48 quarters since. The position peaked at $19.6M in Q1 2021. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • JP Morgan Chase held 145,948 shares of Pacific Biosciences worth $252K as of Q2 2026.
  • JP Morgan Chase bought 7,444 Pacific Biosciences shares in Q2 2026, an estimated $10.8K.
  • Pacific Biosciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5498 holding.
  • JP Morgan Chase first reported a position in Pacific Biosciences in Q2 2013 and has held it in 48 quarters since.
  • JP Morgan Chase's Pacific Biosciences position peaked at $19.6M in Q1 2021.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.